Phosphatidylinositol 3-kinase is involved in α2(I) collagen gene expression in normal and scleroderma fibroblasts

Journal of Immunology

Volumn 172, Issue 11, 2004, Pages 7123-7135

  Asano, Yoshihide ^a   Ihn, Hironobu ^a   Yamane, Kenichi ^a   Jinnin, Masatoshi ^a   Mimura, Yoshihiro ^a   Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; COLLAGEN TYPE 1; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SCLERODERMA; SIGNAL TRANSDUCTION; SKIN DISEASE; SYSTEMIC SCLEROSIS;

EID: 2442640271     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.11.7123     Document Type: Article

References (41)

1. LeRoy, E. C. 1992. Systemic sclerosis (scleroderma). In Cecil Textbook of Medicine 19th Ed. J. B. Wyngaarden, L. H. Smith, and J. C. Bennett, eds. W. B. Saunders, Philadelphia, p. 1530.
2. Korn, J. H. 1989. Immunologic aspects of scleroderma. Curr. Opin. Rheumatol. 1:479.
3. Mauch, C., and T. Krieg. 1990. Fibroblast-matrix interactions and their role in the pathogenesis of fibrosis. Rheum. Dis. Clin. N. Am. 16:93.
4. Jelaska, A., M. Arakawa, G. Broketa, and J. H. Korn. 1996. Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts: increased proportion of high collagen-producing cells in systemic sclerosis fibroblasts. Arthritis Rheum. 39:1338.
5. Mauch, C., E. Kozlowska, B. Eckes, and T. Krieg. 1992. Altered regulation of collagen metabolism in scleroderma fibroblasts grown within three-dimensional collagen gels. Exp. Dermatol. 1:185.
6. Wahl, S. M. 1994. Transforming growth factor β: the good, the bad, and the ugly. J. Exp. Med. 180:1587.
7. LeRoy, E. C. 1974. Increased collagen synthesis by SSc skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast. J. Clin. Invest. 54:880.
8. Buckingham, R. B., R. K. Prince, G. P. Rodnan, and F. Taylor. 1978. Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis (scleroderma). J. Lab. Clin. Med. 92:5.
9. Peltonen, J., L. Kahari, J. Uitto, and S. A. Jimenez. 1990. Increased expression of type VI collagen genes in systemic sclerosis. Arthritis Rheum. 33:1829.
10. Xu, W. D., E. C. LeRoy, and E. A. Smith. 1991. Fibronectin release by systemic sclerosis and normal dermal fibroblasts in response to TGF-β. J. Rheumatol. 18:241.
11. Rudnicka, L., J, Varga, A. M. Christiano, R. V. Iozzo, S. A. Jimenez, and J. Uitto. 1994. Elevated expression of type VII collagen in the skin of patients with systemic sclerosis: regulation by transforming growth factor-β. J. Clin. Invest. 93:1709.
12. Falanga, V., S. L. Tiegs, S. P. Alstadt, A. B. Roberts, and M. B. Sporn. 1987. Transforming growth factor-β: selective increase in glycosaminoglycan synthesis by cultures of fibroblasts from patients with progressive systemic sclerosis. J. Invest. Dermatol. 89:100.
13. Massague, J. 1990. Transforming growth factor-β family. Annu. Rev. Cell. Biol. 6:597.
14. LeRoy, E. C., E. A. Smith, M. B. Kahaleh, M. Trojanowska, and R. M. Silver. 1989. A strategy for determining the pathogenesis of systemic sclerosis: is transforming growth factor β the answer? Arthritis Rheum. 32:817.
15. Kawakami, T., H. Ihn, W. Xu, E. Smith, C. LeRoy, and M. Trojanowska. 1998. Increased expression of TGF-β receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-β signaling to scleroderma phenotype. J. Invest. Dermatol. 110:47.
16. Ihn, H., K. Yamane, M. Kubo, and K. Tamaki. 2001. Blockade of endogenous transforming growth factor β signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor β receptors. Arthritis Rheum. 44:474.
17. Derynck, R., Y. Zhang, and X. H. Feng. 1998. Smads: transcriptional activators of TGF-β responses. Cell 95:737.
18. Zhang, Y., X. Feng, R. We, and R. Derynck. 1996. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 383:168.
19. Dennler, S., S. Itoh, D. Vivien, P. ten Dijke, S. Huet, and J. M. Gauthier. 1998. Direct binding of Smad3 and Smad4 to critical TGF β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:3091.
20. Labbe, E., C. Silvestri, P. A. Hoodless, J. A. Wrana, and L. Attisano. 1998. Smad2 and Smad3 positively and negatively regulate TGF-β-dependent transcription through the forkhead DNA-binding protein FAST2. Mol. Cell. 2:109.
21. WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc. Natl. Acad. Sci. USA 95:6733.
22. Chen, S., W. Yuan, Y. Mori, A. Levenson, M. Trojanowska, and J. Varga. 1999. Stimulation of type I collagen transcription in human skin fibroblasts by TGF-β: involvement of Smad3. J. Invest. Dermatol. 112:49.
23. Tsukazaki, T., T. A. Chiang, A. F. Davison, L. Attisano, and J. L. Wrana. 1998. SARA, a FYVE domain protein that recruits Smad2 to the TGF-β receptor. Cell 95:779.
24. Itoh, F., N. Divecha, L. Brocks, L. Oomen, H. Janssen, J. Calafat, S. Itoh, and P. ten Dijke. 2002. The FYVE domain in Smad anchor for receptor activation (SARA) is sufficient for localization of SARA in early endosomes and regulates TGF-β/Smad signalling. Genes Cells 7:321.
25. Goto, D., H. Nakajima, Y. Mori, K. Kurasawa, N. Kitamura, and I. Iwamoto. 2001. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-β/Smad3 signaling. Biochem. Biophys. Res. Commun. 281:1100.
26. Ihn, H., K. Yamane, Y. Asano, M. Kubo, and K. Tamaki. 2002. IL-4 up-regulates the expression of tissue inhibitor of metalloproteinase-2 in dermal fibroblasts via the p38 mitogen-activated protein kinase-dependent pathway. J. Immunol. 168:1895.
27. Ihn, H., K. Ohnishi, T. Tamaki, E. C. LeRoy, and M. Trojanowska. 1996. Transcriptional regulation of the human α2(I) collagen gene: combined action of upstream stimulatory and inhibitory cis-acting elements. J. Biol. Chem. 271:26717.
28. Ihn, H., E. C. LeRoy, and M. Trojanowska. 1997. Oncostatin M stimulates transcription of the human α2(I) collagen gene via the Sp1/Sp3-binding site. J. Biol. Chem. 272:24666.
29. Poncelet, A. C., and H. W. Schnaper. 2001. Sp1 and Smad proteins cooperate to mediate transforming growth factor-β1-induced α2(I) collagen expression in human glomerular mesangial cells. J. Biol. Chem. 276:6983.
30. Ihn, H., and K. Tamaki. 2000. Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: association with increased expression of the type 1 collagen gene. Arthritis Rheum. 43:2240.
31. Yagi, K., M. Furuhashi, H. Aoki, D. Goto, H. Kuwano, K. Sugamura, K Miyazono, and M. Kato. 2002. c-myc is a downstream target of the Smad pathway. J. Biol. Chem. 277:854.
32. Davidson, J., and R. Berg. 1981. Posttranslational events in collagen biosynthesis. Methods Cell Biol. 23:119.
33. Rosenbloom, J., M. Harsch, and S. Jimenez. 1973. Hydroxyproline content determines the denaturation temperature of chick tendon collagen. Arch. Biochem. Biophys. 158:478.
34. Geesin, J. C., D. Darr, R. Kaufman, S. Murad, and S. R. Pinnell. 1988. Ascorbic acid specifically increases type I and type III procollagen messenger RNA levels in human skin fibroblast. J. Invest. Dermatol. 90:420.
35. Murad, S., S. Tajima, G. R. Johnson, S. Sivarajah, and S. R. Pinnell. 1983. Collagen synthesis in cultured human skin fibroblasts: effect of ascorbic acid and its analogs. J. Invest. Dermatol. 81:158.
36. Tamaki, T., K. Ohnishi, C. Hartl, E. C. LeRoy, and M. Trojanowska. 1995. Characterization of a GC-rich region containing Sp1 binding site(s) as a constitutive responsive element of the α2(I) collagen gene in human fibroblasts. J. Biol. Chem. 270:4299.
37. Ricupero, D. A., C. F. Poliks, D. C. Rishikof, K. A. Cuttle, P. Kuang, and R. H. Goldstein. 2001. Phosphatidylinositol 3-kinase-dependent stabilization of α1(I) collagen mRNA in human lung fibroblasts. Am. J. Physiol. Cell Physiol. 281:C99.
38. Eckes, B., C. Mauch, G. Huppe, and T. Krieg. 1996. Differential regulation of transcription and transcript stability of pro-α1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma. Biochem. J. 315:549.
39. Kubo, M., H. Ihn, K. Yamane, and K. Tamaki. 2002. Upregulated expression of transforming growth factor-β receptors in dermal fibroblasts of skin sections from patients with systemic sclerosis. J. Rheumatol. 29:2558.
40. Yamane, K., H. Ihn, and K. Tamaki. 2002. Increased transcriptional activities of transforming growth factor-β receptors in scleroderma fibroblasts. Arthritis Rheum. 46:2421.
41. Lim, I. J., T. T. Phan, E. K. Tan, T. T. Nguyen, E. Tran, M. T. Longaker, C. Song, S. T. Lee, and H. T. Huynh. 2003. Synchronous activation of ERK and phosphatidylinositol 3-kinase pathways is required for collagen and extracellular matrix production in keloids. J. Biol. Chem. 278:40851.